| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| SSD | shaded surface display; single saturating dose; Social Security disability; source-skin distance; so... |
| SL | sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen... |
| NAD | neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini... |
| AIMS | Abnormal Involuntary Movement Scale |
|---|---|
| AIM | abnormal involuntary movement |
| AUB | Abnormal Uterine Bleeding |
| Awd | Abnormal wing disc |
| TAM | Transient abnormal myelopoiesis |
| plant growth substances | <plant biology> Substances that, at low concentration, influence plant growth and differentiation. Formerly referred to as plant hormones or phytohormones, these terms are now suspect because some aspects of the hormone concept, notably action at a distance from the site of synthesis, do not necessarily apply in plants. Also called plant growth regulators. The major classes are absicisic acid, auxin, cytokinin, ethylene and gibberellin, others include steroid and phenol derivatives. (31 Dec 1997) |
|---|---|
| hazardous substances | Substances which, upon release into the atmosphere, water, or soil, or which, in direct contact with the skin, eyes, or mucous membranes, or as additives to food, cause health risks to humans or animals through absorption, inhalation, or ingestion. The concept includes safe handling, transportation, and storage of these substances. (12 Dec 1998) |
| thiobarbituric acid reactive substances | Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct. (12 Dec 1998) |
| toxic substances | A chemical or mixture of chemicals that presents a high risk of injury to human health or to the environment. (05 Dec 1998) |
| carbon source | Any carbon-containing organic molecule (carbohydrate, aminoacid) that an organism can use to produce energy in the form of ATP. (09 Oct 1997) |
| major source | A source that emits, or has the potential to emit, a pollutant regulated under the Clean Air act in excess of a specified rate in a nonattainment area. (05 Dec 1998) |
| common-source epidemic | <microbiology> An epidemic resulting from infection of a large number of people from a single contaminated source. (09 Oct 1997) |
| point source | In photometry, a very small source of light which is regarded as a geometrical point from which light emanates in straight lines in all directions. (05 Mar 2000) |
| power source | Devices that supply energy. (12 Dec 1998) |
| source emission reduction plan | (SERP) A contingency plan developed to reduce emissions during an air quality emergency. (05 Dec 1998) |
| abnormal | Not normal, contrary to the usual structure, position, behaviour or rule. (06 Oct 1997) |
| abnormal cleavage of cardiac valve | Congenital malformation of a valve leaflet with a defect extending from the free margin. (05 Mar 2000) |
| abnormal correspondence | Abnormal correspondence, a condition, frequent in strabismus, in which corresponding retinal points do not have the same visual direction; the fovea of one eye corresponds to an extrafoveal area of the fellow eye. Synonym: abnormal correspondence. (05 Mar 2000) |
| abnormal heart chamber dimensions | <radiology> Left ventricular volume overload, left ventricular hypertrophy, right ventricular volume overload, right ventricular hypertrophy, fixed subvalvular aortic stenosis, hypoplastic left/right ventricle; common ventricle, congestive cardiomyopathy (12 Dec 1998) |
| abnormal occlusion | An arrangement of the teeth which is not considered to be within the normal range of variation. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|